产品: SLC40A1 抗体
货号: DF13561
描述: Rabbit polyclonal antibody to SLC40A1
应用: WB IHC
文献验证: WB, IHC
反应: Human, Mouse, Rat
预测: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Chicken, Xenopus
蛋白号: Q9NP59
RRID: AB_2846580

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1500 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
SLC40A1 Antibody detects endogenous levels of total SLC40A1.
RRID:
AB_2846580
引用格式: Affinity Biosciences Cat# DF13561, RRID:AB_2846580.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

Ferroportin 1; Ferroportin; Ferroportin-1; FPN1; HFE4; IREG1; iron regulated gene 1; Iron regulated transporter 1; Iron-regulated transporter 1; MST079; MSTP079; MTP1; putative ferroportin 1 variant IIIA; putative ferroportin 1 variant IIIB; S40A1_HUMAN; SLC11A3; SLC11A3, formerly; SLC40A1; solute carrier family 11 (proton-coupled divalent metal ion transporters), member 3; solute carrier family 11 (proton-coupled divalent metal ion transporters), member 3, formerly; solute carrier family 40 (iron-regulated transporter), member 1; Solute carrier family 40 member 1;

抗原和靶标

免疫原:

A synthesized peptide derived from human SLC40A1, corresponding to a region within N-terminal amino acids.

基因/基因ID:

研究领域

· Cellular Processes > Cell growth and death > Ferroptosis.   (View pathway)

· Organismal Systems > Digestive system > Mineral absorption.

文献引用

1). Modified Fish-Skin-Collagen-Based Hydrogels with Antioxidant and Antibacterial Functions for Diabetic Wound Healing. Advanced Healthcare Materials, 2025 [IF=9.6]

2). Bone morphogenetic protein 4 derived from the cerebrospinal fluid in patients with postherpetic neuralgia induces allodynia via the crosstalk between microglia and astrocyte. Brain, behavior, and immunity, 2024 (PubMed: 38735405) [IF=8.8]

3). Voluntary exercise alleviates neural functional deficits in Parkinson's disease mice by inhibiting microglial ferroptosis via SLC7A11/ALOX12 axis. NPJ Parkinson's disease, 2025 (PubMed: 40122927) [IF=8.7]

4). Defective ferritinophagy and imbalanced iron metabolism in PBDE-47-triggered neuronal ferroptosis and salvage by Canolol. The Science of the total environment, 2024 (PubMed: 38750757) [IF=8.2]

5). GSK-3β-dependent Nrf2 antioxidant response modulates ferroptosis of lens epithelial cells in age-related cataract. Free Radical Biology and Medicine, 2023 (PubMed: 37156294) [IF=7.1]

6). Melatonin ameliorates neurological deficits through MT2/IL-33/ferritin H signaling-mediated inhibition of neuroinflammation and ferroptosis after traumatic brain injury. Free radical biology & medicine, 2023 (PubMed: 36805045) [IF=7.1]

7). Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis. Biomedicine & Pharmacotherapy, 2023 (PubMed: 36379122) [IF=6.9]

8). Protective benefits of salvianic acid A against retinal iron overload by inhibition of ferroptosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023 (PubMed: 37429233) [IF=6.9]

9). Dihydroartemisinin inhibits galectin-1-induced ferroptosis resistance and peritoneal metastasis of gastric cancer via the Nrf2-HO-1 pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2025 (PubMed: 41166905) [IF=6.7]

Application: IHC    Species: human    Sample: GC tissues

Fig. 8. Clinical significance of Nrf2/HO-1/GPX4 expression in GC. An analysis of the GEPIA database revealed the expression levels of NFE2L2 (A), HMOX1 (B), and GPX4 (C) in GC tissues compared with normal tissues, along with their prognostic significance for GC patients. (D) The correlation analysis between HMOX1 and NFE2L2 expression and between HMOX1 and GPX4 expression in GC tissues was performed using the GEPIA database. (E–H) Western blot analysis of Nrf2, HO-1, and GPX4 expression in GC tissues and adjacent noncancer tissues. (I, J) Immunofluorescence staining was performed to analyse the expression of Nrf2, HO-1, and GPX4 in GC tissues from patients with or without PM (400 × magnification), followed by relative fluorescence quantification. (K) GC tissues obtained from patients with or without PM were processed for H&E staining, iron staining, and IHC for TfR1 and FPN1 (400 × magnification). (L) The IODs of iron staining and the IRSs of TfR1 and FPN1 in each group were compared.

10). Moderate static magnetic field regulates iron metabolism and salvage bone loss caused by iron accumulation. Journal of orthopaedic translation, 2025 (PubMed: 40171108) [IF=5.9]

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.